3 Thriving Biotech Stocks Surviving Coronavirus-Infected Markets
Some stocks are defying gravity amidst the coronavirus-related plunge. Select biotech firms developing vaccines or treatments for the respiratory illness are among the winners. Clinical trials are either underway or set to begin. Since last week’s close, the S&P 500 index has dropped from 3338 points to around 3070
Read More